What Rezolute, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 9 |
| Sells | 0 | 0 |
| Total trades | 4 | 29 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 8,000 | 845,750 |
| Disposed | 18,267 | 82,890 |
| Net activity | −10,267 | +762,860 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Evans Daron | CFO | Oct 21 | Gift · G | +4,000 | — | — | 11,000 |
| Evans Daron | CFO | Oct 21 | Gift · G | +4,000 | — | — | 11,000 |
| Evans Daron | CFO | Oct 21 | Gift · G | −16,000 | — | — | 395,400 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Sep 02 | Withheld — tax / exercise cost · F | −2,267 | $4.50 | −$10.2K | 69,275 |
| Evans Daron | CFO | Jul 02 | Withheld — tax / exercise cost · F | −3,062 | $4.99 | −$15.3K | 411,400 |
| Elam Nevan C | CEO | Jul 02 | Withheld — tax / exercise cost · F | −8,004 | $4.99 | −$39.9K | 605,497 |
| Roberts Brian Kenneth | Chief Medical Officer | Jul 02 | Withheld — tax / exercise cost · F | −3,062 | $4.99 | −$15.3K | 293,851 |
| Evans Daron | CFO | Mar 30 | Open-market buy · P | +10,000 | $2.85 | +$28.5K | 414,462 |
| Evans Daron | CFO | Mar 02 | Withheld — tax / exercise cost · F | −11,438 | $2.99 | −$34.2K | 404,462 |
| Elam Nevan C | CEO | Mar 02 | Withheld — tax / exercise cost · F | −27,618 | $2.99 | −$82.6K | 613,501 |
| Roberts Brian Kenneth | Chief Medical Officer | Mar 02 | Withheld — tax / exercise cost · F | −11,439 | $2.99 | −$34.2K | 296,913 |
| Roberts Brian Kenneth | Chief Medical Officer | Dec 16 | Open-market buy · P | +28,000 | $1.70 | +$47.6K | 308,352 |
| Hogenhuis Wladimir | Director | Dec 16 | Open-market buy · P | +5,650 | $1.69 | +$9.55K | 119,675 |
| Evans Daron | CFO | Dec 15 | Open-market buy · P | +2,500 | $1.79 | +$4.48K | 7,000 |
| Evans Daron | CFO | Dec 15 | Open-market buy · P | +2,500 | $1.79 | +$4.46K | 7,000 |
| Evans Daron | CFO | Dec 15 | Open-market buy · P | +40,000 | $1.77 | +$70.6K | 415,900 |
| Elam Nevan C | CEO | Dec 15 | Open-market buy · P | +32,000 | $1.59 | +$50.9K | 641,119 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Dec 15 | Open-market buy · P | +100 | $1.60 | +$160 | 71,542 |
| Karnawat Sunil Ratilal | Chief Commercial Officer | Dec 15 | Open-market buy · P | +12,000 | $1.62 | +$19.4K | 71,442 |
| Kreher Nerissa | Director | Nov 19 | Grant / award · A | +21,000 | — | — | 58,576 |
Loading...
